http://www.cosmiverse.com/science01080204.html
January 8, 2002 8:00 CDT
A University of Chicago researcher
says drugs that reduce an aspect of immune system activity could help many
women facing infertility problems to give birth. Alan Beer studied women
with unexplained infertility who failed to carry a child to term after
recurrent IVF treatments.
Although fertilized embryos had been
transplanted into their uteruses, these women repeatedly miscarried. Beer
found that 70 percent of women with three IVF failures had elevated levels
of an immune system chemical called tumor necrosis factor alpha. TNF alpha
is involved in the immune inflammatory response.
People who suffer from autoimmune
diseases such as multiple sclerosis and rheumatoid arthritis have higher
than normal levels of TNF alpha. Beer suspected that the high levels could
damage a developing embryo, and gave 100 fertility patients drugs that
are often used to reduce TNF alpha levels, then repeated IVF treatments.
The results of the trial were released
Monday at a meeting of the British Fertility Society in Nottingham, UK.
Simon Thornton of the CARE fertility clinic at the Park Hospital in Nottingham
says the data is impressive. Beer "has shown astonishing success rates
in patients who would otherwise have had very low success rates", he told
the BBC.
Thornton says reducing TNF alpha
levels could even be an alterative to IVF for some women: "At present,
we use IVF as a treatment for many patients who have unexplained infertility
- but this may be a much more straightforward treatment to allow them to
have a perfectly successful pregnancy."
But the immune system's impact on
a pregnancy is complex, say fertility researchers. Last year, a team at
the National Institutes of Health found that a hormone produced by the
uterus wall and the developing embryo can trigger active killer T cells
to commit suicide. The team think lower than normal levels of the hormone
might explain some cases of recurrent miscarriage in women.
© 1999-2000 Cosmiverse.com